AUTHOR=Yu Weiyi , He Ji , Liu Xiangyi , Wu Jieying , Cai Xiying , Zhang Yingshuang , Liu Xiaoxuan , Fan Dongsheng 

TITLE=Clinical features and genetic spectrum of Chinese patients with hereditary spastic paraplegia: A 14-year study

JOURNAL=Frontiers in Genetics

VOLUME=14

YEAR=2023

URL=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.1085442

DOI=10.3389/fgene.2023.1085442

ISSN=1664-8021

ABSTRACT=<p><bold>Background:</bold> Hereditary spastic paraplegia (HSP) constitutes a group of clinically and genetically rare neurodegenerative diseases characterized by progressive corticospinal tract degeneration. The phenotypes and genotypes of HSP are still expanding. In this study, we aimed to analyse the differential diagnosis, clinical features, and genetic distributions of a Chinese HSP patients in a 14-year cohort and to improve our understanding of the disease.</p><p><bold>Methods:</bold> The clinical data of patients with a primary diagnosis of HSP at the initial visit to the Department of the Neurology, Peking University Third Hospital, from 2008 to 2022 were retrospectively collected. Next-generation sequencing gene panels (NGS) combined with a multiplex ligation-amplification assay (MLPA) were conducted. Epidemiological and clinical features and candidate variants in HSP-related genes were analyzed and summarized.</p><p><bold>Results:</bold> 54 cases (probands from 25 different pedigrees and 29 sporadic cases) from 95 patients with a primary diagnosis of HSP were finally confirmed to have a clinical diagnosis of HSP based on clinical criteria, including their clinical findings, family history and long-term follow-up. Earlier disease onset was associated with longer diagnostic delay and longer disease duration and was associated with a lower risk of loss of ability to walk independently. In addition, 20 candidate variants in reported HSP-related genes were identified in these clinically diagnosed HSP patients, including variants in <italic>SPAST, ALT1, WASHC5, SPG11, B4GALNT1,</italic> and <italic>REEP1</italic>. The genetic diagnostic rate in these 54 patients was 35.18%.</p><p><bold>Conclusion:</bold> Hereditary spastic paraplegia has high clinical and genetic heterogeneity and is prone to misdiagnosis. Long-term follow-up and genetic testing can partially assist in diagnosing HSP. Our study summarized the clinical features of Chinese HSP patients in a 14-year cohort, expanded the genotype spectrum, and improved our understanding of the disease.</p>